Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Teloken

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
BJU International|June 25, 2011
Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE studyMichael Marberger, Stephen J Freedland, Gerald L Andriole, et al.
The Journal of Urology|January 13, 2006
Multi-institutional validation of vasectomy reversal predictorSijo J Parekattil, Wayne Kuang, Peter N Kolettis, et al.
BJU International|June 10, 2008
Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunctionJoão Afif-Abdo, Claudio Teloken, Ronaldo Damião, et al.
Revista Do Hospital Das Clinicas|November 16, 2004
Urethral catheter removal 7 or 14 days after radical retropubic prostatectomy: clinical implications and complications in a randomized studyCarlos Ary Vargas Souto, Ernani Luis Rhoden, Rafael De Conti, et al.
The New England Journal of Medicine|April 2, 2010
Effect of dutasteride on the risk of prostate cancerGerald L Andriole, David G Bostwick, Otis W Brawley, et al.
The Journal of Urology|November 16, 2010
The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE studyGerald L Andriole, David Bostwick, Otis W Brawley, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
BJU International|June 25, 2011
Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE studyMichael Marberger, Stephen J Freedland, Gerald L Andriole, et al.
The Journal of Urology|January 13, 2006
Multi-institutional validation of vasectomy reversal predictorSijo J Parekattil, Wayne Kuang, Peter N Kolettis, et al.
BJU International|June 10, 2008
Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunctionJoão Afif-Abdo, Claudio Teloken, Ronaldo Damião, et al.
Revista Do Hospital Das Clinicas|November 16, 2004
Urethral catheter removal 7 or 14 days after radical retropubic prostatectomy: clinical implications and complications in a randomized studyCarlos Ary Vargas Souto, Ernani Luis Rhoden, Rafael De Conti, et al.
The New England Journal of Medicine|April 2, 2010
Effect of dutasteride on the risk of prostate cancerGerald L Andriole, David G Bostwick, Otis W Brawley, et al.
The Journal of Urology|November 16, 2010
The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE studyGerald L Andriole, David Bostwick, Otis W Brawley, et al.
Pageof 2